1. 朔 啓太*,横田 翔平 HFrEFの心拍管理におけるイバブラジンの使い方 令和の心不全治療ガイド.19-23,2022.
2. Kinoshita H, Saku K, Mano J, Mannoji H, Kanaya S, Sunagawa K. Very short-term beat-by-beat blood pressure variability in the supine position at rest correlates well with the nocturnal blood pressure variability assessed by ambulatory blood pressure monitoring. Hypertension Research 2022. DOI:10.1038/s41440-022-00911-6.
3. 横田 翔平, 此内 緑, 朔 啓太* 自律神経制御による循環器疾患治療 -病態生理からみた現状分析と課題- 自律神経. 2022, in press.
4. Kawada T*, Nishikawa T, Hayama Y, Li M, Zheng C, Uemura K, SakuK , MiyamotoT , Sugimachi M. Quantitative assessment of the central versus peripheral effect of intravenous clonidine using baroreflex equilibrium diagrams. J Physiol Sci. 71(1):39, 2021. DOI: 10.1186/s12576-021-00824-y
5. Kawada T*, Yamamoto H, MiyamotoT , Hayama Y, Li M , Zheng C, Uemura K, Sugimachi M, Saku K. Ivabradine increases the high frequency gain ratio in the vagal heart rate transfer function via an interaction with muscarinic potassium channels. Physiol Rep. 9(23): e15134, 2021. DOI: 10.14814/phy2.15134
6. Saku K*, Yokota S, Nishikawa T , Kinugawa K.Interventional heart failure therapy: A new concept fighting against heart failure. J Cardiol. 16;S0914-5087(21)00339-7, 2021. DOI: 10.1016/j.jjcc.2021.11.018
7. Saku K*, Nakata J.How Should We Develop New Risk Scores for Cardiogenic Shock? Circ J. Vol. 86 , No. 4 pp. 695-698, 2021. DOI: 10.1253/circj.CJ-21-0953
8. Umemoto S, Abe K*, Hosokawa K, Horimoto K, Saku K, Sakamoto T, Tsutsui H.Increased Pulmonary Arterial Compliance after Balloon Pulmonary Angioplasty Predicts Exercise Tolerance Improvement in Inoperable CTEPH Patients with Lower Pulmonary Arterial Pressure. Heart Lung. 52: 8-15, 2021. DOI: 10.1016/j.hrtlng.2021.11.003
9. Kawada T*, Saku K, Miyamoto T. Closed-Loop Identification of Baroreflex Properties in the Frequency Domain. Front Neurosci. 15: 694512, 2021. DOI: 10.3389/fnins.2021.694512
10. Nishikawa T*, Uemura K, Hayama Y, Kawada T, Saku K, Sugimachi M. Development of an automated closed-loop β-blocker delivery system to stably reduce myocardial oxygen consumption without inducing circulatory collapse in a canine heart failure model: a proof of concept study. J Clin Monit Compu, 2021. DOI: 10.1007/s10877-021-00717-w